CorMedix Inc. (CRMD): Total Assets
$826.14M
As of 2025-12-31
$904.05M
As of 2026-06-30
+137.0%
3-year compound annual growth
+75.7%
5-year compound annual growth
+36.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $826.14M | +595.1% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $118.85M | +44.8% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $82.06M | +32.3% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $62.04M | -10.0% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $68.95M | +39.8% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $49.31M | +67.3% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $29.48M | +56.6% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $18.83M | +39.9% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $13.45M | -38.6% | 2019-05-29, Balance as of period end |
| 2016-12-31 | $21.91M | -41.0% | 2018-03-19, Balance as of period end |
| 2015-12-31 | $37.10M | +627.8% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $5.10M | +71.8% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $2.97M | +157.3% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $1.15M | -54.9% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $2.56M | -71.1% | 2014-03-04, Balance as of period end |
| 2010-12-31 | $8.85M | n/a | 2012-04-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| CorMedix Inc. (CRMD) | 2025-12-31 | $826.14M | +595.1% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $225.87M | -2.9% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $396.90M | +13.1% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $383.53M | +18.7% |
| MannKind Corp (MNKD) | 2025-12-31 | $792.18M | +101.1% |
| Harrow, Inc. (HROW) | 2025-12-31 | $399.48M | +2.7% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $817.15M | +193.0% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $1.56B | +65.7% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $717.90M | -34.2% |
Compare CRMD, EOLS, IRWD, XERS side by side · Screen every company in Pharmaceutical Preparations ↗